PETVW
PetVivo Holdings, Inc. [PETVW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PETVW Stock Summary
In the News
PETVW Financial details
Company Rating
-
Market Cap
772.25K
Income
-10.63M
Revenue
1.05M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
25
Optionable
No
Shortable
Yes
Earnings
31 Dec 2022
P/E
-1.35
Forward P/E
-
PEG
-0.24
P/S
17.48
P/B
15.24
P/C
-
P/FCF
-2.08
Quick Ratio
0.11
Current Ratio
1.05
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.87
EPS next Y
-
EPS next Q
-
EPS this Y
51.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.77%
Revenue last 5Y
63.74%
Revenue Q/Q
187.36%
EPS Q/Q
-57.14%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-276%
ROE
-1546%
ROC
-4.89%
Gross Margin
43%
Oper. Margin
-1092%
Profit Margin
-1166%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.05425-0.05425
52W High
-
52W Low
-
RSI
47.93
Rel Volume
-
Avg Volume
-
Volume
95.66K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
2.1
-
-
Volatility
0.01%, 0.01%
Prev Close
-49.9%
Price
0.025
Change
-49.9%
Company Profile
- Market Capitalization 772.25K
- Employee 25
- CEO Mr. John Lai
- Headquarters Minneapolis,MN,US
- IPO Date 2021-08-11
-
Website
http://www.petvivo.com 
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
